Reporting owner · CIK 0000771999

DSS, INC.

SEC Form 4 history for the last 180 days across 1 company, 3 transactions and 1 filing.

10%IMPACT BIOMEDICAL INC.
Open-market transaction mix0% buys0 buys · 3 sales

Period: Last 180 days

Trade dates in this period: Sep 22, 2026 – Sep 24, 2026

Transaction history, summary figures and purchase returns cover the last 180 days. Earlier activity is excluded from those sections.

Filings1Form 4 records
Buying$00 purchases
Selling$1.69k3 sales
Net value−$1.69kBuys minus sells · disclosed values

Latest insider transactions

Form 4 filings from the last 180 days.
DSS, INC. transactions · 20 per page
CompanyActivityDisclosed valueFiled (ET)
IBOIMPACT BIOMEDICAL INC.
10% owner
10%
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$1.10kView disclosure →
IBOIMPACT BIOMEDICAL INC.
10% owner
10%
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$188View disclosure →
IBOIMPACT BIOMEDICAL INC.
10% owner
10%
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$398View disclosure →

Latest Form 4 facts

Quick context from source filings

Latest open-market transaction

The insider reported a sale at IMPACT BIOMEDICAL INC. on Sep 24, 2026 valued at $1,101.16.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Monthly open-market activity

Last 1 reported month · purchases and sales

View exact monthly values
Monthly open-market source values
MonthPurchasesSalesBuy valueSale valueNet value
Sep 202603$0$1,686.46−$1,686.46

Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.

Ownership and transaction size

Ownership and ticket size

Average P/S size$562
Median P/S size$398
Direct3
Indirect0
Sep 24, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Associated companies

Counts cover all available history, including outside the summary period

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
No open-market purchases in the last 180 days

A 90-day purchase return requires an open-market buy. None is recorded in the last 180 days. Purchases filed earlier are outside the visible history and are not included.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

3 observations · Sep 22, 2026 – Sep 24, 2026. Window ends at the latest available report, not today.

Selected observation · Sep 24, 2026589,518 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
Sep 22, 2026589,701Sep 24, 2026View transaction
Sep 23, 2026589,674Sep 24, 2026View transaction
Sep 24, 2026589,518Sep 24, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

DSS, INC. Insider Activity FAQ

SEC Form 4 context

Who is DSS, INC.?

DSS, INC. is a reporting owner in SEC Form 4 filings with reporting owner CIK 0000771999.

Which companies has DSS, INC. reported transactions for?

IMPACT BIOMEDICAL INC.

When was DSS, INC.'s latest insider buy?

No open-market insider purchase is recorded in the last 180 days. Earlier filings are outside the visible history.

When was DSS, INC.'s latest insider sale?

The insider reported a sale at IMPACT BIOMEDICAL INC. on Sep 24, 2026 valued at $1,101.16.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.